GE HealthCare reported weaker-than-expected Q1 2026 earnings and lowered its full-year adjusted EPS guidance due to a supplier-related product recall and margin pressures. The stock fell 13.2% on the news. Subsequently, the company announced its CFO will step down, appointing an interim replacement while searching for a permanent one. Investors who suffered losses are encouraged to contact the Law Offices of Howard G. Smith regarding potential securities fraud claims.
Centerra Gold is driving growth through a 29% increase in gold production at its Mount Milligan mine and strong financial health with zero long-term debt and $450 million cash. The company raised its 2026 gold production guidance to 260,000-290,000 o...
Agco Corp reported Q2 2026 earnings per share of $1.43, below analyst estimates of $1.47, and revenue of $2.61 billion, missing the forecast of $2.75 billion. Despite the misses, EPS rose from $1.35 a year ago, though revenue declined slightly by 1%....
Grand Canyon Education is preparing to release its Q2 earnings report with analysts expecting an EPS of $1.69 and revenue of $261.8 million. Investor sentiment is mixed, as Arrowstreet Capital reduced its stake while others like Bank of Nova Scotia i...
Boston Scientific reported strong Q2 results with revenue of $5.442 billion and adjusted EPS of $0.86, surpassing analyst expectations. However, RBC Capital lowered the 2026 stock price target from $85 to $70 due to competitive pressures and a reduce...
AST SpaceMobile, a pioneer in space-based cellular broadband, was upgraded by Scotiabank from Underperform to Sector Perform due to improved outlook. The company faced past challenges including competition from Starlink, slow adoption, satellite dela...
